Active ingredients: Linagliptin, metformin HCl; 2.5 mg/500 mg, 2.5 mg/850 mg, 2.5 mg/1,000 mg; tablets. Indication: Adjunct to diet and exercise in type 2 diabetes when treatment with both linagliptin ...
Objective: The purpose of this study was to determine the efficacy and safety of a novel extended-release metformin in patients with type 2 diabetes. Research Design And Methods: Adults with type 2 ...
PrandiMet stimulates release of insulin, improves insulin sensitivity, and decreases gluconeogenesis PrandiMet stimulates the release of insulin, improves insulin sensitivity, and decreases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback